These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6861868)

  • 21. Recommended standard theophylline doses are inadequate in chronic obstructive pulmonary disease.
    Savage J; Wiseman IC
    S Afr Med J; 1987 Apr; 71(8):508-9. PubMed ID: 3563816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.
    Taylor DR; Duffin D; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1984 Jul; 18(1):27-30. PubMed ID: 6743488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent pharmacokinetics with single daily dose slow release theophylline in patients with chronic lung disease.
    Butcher MA; Frazer LA; Reddel HK; Marlin GE
    Br J Clin Pharmacol; 1982 Feb; 13(2):241-3. PubMed ID: 7059426
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical effectiveness of delayed-action theophylline preparations].
    Tsoĭ AN; Gavrilenko LN; Bogovskiĭ BP; Semenova LG; Iuldasheva LI
    Klin Med (Mosk); 1990 Sep; 68(9):72-5. PubMed ID: 2290338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dose titration with Euphylong following prior determination of serum concentration in the steady state].
    Schnabel D; von Treufels S; Oellerich M; Böttger HC; Sybrecht GW
    Pneumologie; 1990 Feb; 44 Suppl 1():287-8. PubMed ID: 2367392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of rifampicin administration on theophylline pharmacokinetics in humans.
    Powell-Jackson PR; Jamieson AP; Gray BJ; Moxham J; Williams R
    Am Rev Respir Dis; 1985 Jun; 131(6):939-40. PubMed ID: 4003946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.
    Williams PE; Alwazir YA; Routledge PA; Campbell IA
    Br J Clin Pharmacol; 1986 Oct; 22(4):383-7. PubMed ID: 3768254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single oral dose method for predicting steady state theophylline concentrations in clinical practice.
    Mann JS; Fitzpatrick RW; Jones PW; Prowse K; Mucklow JC; Cole RB
    Respir Med; 1990 Nov; 84(6):479-84. PubMed ID: 2274687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enoxacin decreases the clearance of theophylline in man.
    Wijnands WJ; Vree TB; Van Herwaarden CL
    Br J Clin Pharmacol; 1985 Dec; 20(6):583-8. PubMed ID: 3867394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of orally administered cimetidine and theophylline on the elimination of each drug in patients with chronic airways obstruction.
    Hsu K; Garton A; Sproule BJ; Tam YK; Legatt D; Herbert FA
    Am Rev Respir Dis; 1984 Nov; 130(5):740-3. PubMed ID: 6497156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent elimination kinetics of theophylline.
    Lesko LJ
    Clin Pharmacokinet; 1979; 4(6):449-59. PubMed ID: 519931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient compliance with oral theophylline therapy.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1984 Jan; 17(1):15-20. PubMed ID: 6691884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter].
    Kaik G
    Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the ordering of serum theophylline concentrations.
    Gentry SM; Keith TD; McMillan DM; Goetter WE
    Am J Hosp Pharm; 1981 Dec; 38(12):1937-9. PubMed ID: 7325177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronopharmacodynamics and kinetics after symmetric and asymmetric multiple theophylline doses in patients with chronic obstructive pulmonary disease.
    Gimeno F; van Veenen R; Berg WC; Steenhuis EJ; Jonkman JH; Weibel MA
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):7-12. PubMed ID: 2744908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylxanthine therapy and reversible airway obstruction.
    McFadden ER
    Am J Med; 1985 Dec; 79(6A):1-4. PubMed ID: 4083294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Time-related distribution of delayed-action theophylline in the treatment of chronic obstructive bronchopneumopathies].
    Philip-Joet F; Bruguerolle B; Parrel M; Vestri R; Arnaud A
    Presse Med; 1988 Feb; 17(5):193-6. PubMed ID: 2965374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
    Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
    Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daily maintenance dose of a long-acting theophylline from a single theophylline serum level.
    Goldstein RS; Allen LC; Thiessen JJ; Michalko K; Dayneka N; Woolf CR
    Chest; 1986 Jan; 89(1):103-8. PubMed ID: 3940768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of single and multiple dose pharmacokinetics of theophylline using stable isotopes.
    Vestal RE; Thummel KE; Mercer GD; Koup JR
    Eur J Clin Pharmacol; 1986; 30(1):113-20. PubMed ID: 3709624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.